ClinicalTrials.gov
public full text
Public Domain
A Study of LY2228820 in Participants With Advanced Cancer
The objective of this study is to determine a safe dose of LY2228820 that may be given to participants with advanced cancer. Part A of this study will consist of dose escalation, and Part B will consist of dose confirmation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY2584702 in Participants With Advanced Cancer#911461
- A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients#1138692
- A Phase 1 Study of LY2835219 In Participants With Advanced Cancer#899161
- Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers#839151
- A Study of LY3451838 in Healthy Participants#912795
Record · ID 836269
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive